Capítulo 2.3. Insuficiencia muscular respiratoria

Bibliografía
 
1. Blázquez MªV, Rodriguez R. Avances en fallo hepático fulminante. En: Libro del año de Aparato Digestivo 1996. Sanidad S.A eds. ( SANED). 1996;1: 200-201.
2. Almdal T, Schroeder T, Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver disease. Scand J Gastroenterol 1989; 24:299-303.
3. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver faliure: definitions and causes. Semin Liver Dis 1986;6:97-106.
4. O`Grady J, Williams R. Acute liver faliure. Baillière´s Clinical Gastroenterology 1989;3:75-89.
5. Levin S, Hahn T,. Interferon deficiency syndrome. Clin Exp Inmunol 1985;60:267-273.
6. Papaevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C. Etiology of fulminant viral hepatitis in Grecce. Hepatology 1984; 4:369-372.
7. Forbes A, Williams R. Increasing age: an important adverse prognostic factor in hepatitis A infection. J R Coll Physicians Lond 1988;21:2435-2438.
8. Lemon SM. Type A viral hepatitis: new developments in an old disease. N Engl J Med 1985;13:19-24.
9. Vallbracht A, Gabriel P, Maier K. et al: Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology 1986; 6:1308-1314.
10. McNeil M, Hoy JF, Richards MJ. Aetiology of fatal viral hepatitis in Melbourne: a restrospective study. Med J Aust 1984;141:637-640.
11. Caraceni P, Van Thiel D, Acute liver failure. Lancet 1995;345:163-169.
12. Larsen FS, Ejlersen E, Hansen BA, Knudsen GM, Tygstrup N, Secher HN. Functional loss of cerebral blood flow autorregulation in patients with fulminant hepatic failure. J Hepatol 1995;23 (2):212-217.
13. Kramer DJ. Fulminant hepatic faliure update 1996 (in Press)
14. Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, Potter DR. Effects of intraoperative N-acetylcysteine
in orthotopic liver transplantation. Br J Anaesth 1995; 75 (3):352-354.
15. Clemmesen J, Larsen F, Rasmussen A, Hansen B. Is a initial small spectrum antibiotic regimen safe in fulminant hepatic failure ?. Transplant Proc 1995;27 (6):3505.
16. Jauregui HO, Mullon CJ, Trenkler D, Naik S, Santangini H, Press P, Muller TE Solomon BA. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995; 21 (2): 460-469..
17. Van Hoeck B, Ringers J, Masclee AA, Van Krikken LG, Haak HR, Lameers CB, Tersptra OT. Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B. J Hepatol 1995; 23 (2): 460-469.
18. Tada K, Akamatsu K, Yamamoto S, Wakabayashi T, Ohta Y. Clinical significance of antiphospholipid antibodies in fulminant hepatic failure. Hepatogastroenterology 1995;42 (1) : 27-30.
19. Shiota G, Okano J, Kawasaky H, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995;21 (1):106-12.
20. Acharya SK, Dasarathy S, Irshad M. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality. J Hepatol 1995; 23 (1): 8-13.
21. Arankalle VA, Ticechurst J, Sreenivasan MA. Aetiological association of a virus-like particle with enterically transmitted non-A non-B hepatitis. Lancet 1988; 1:550-554.
22. Basile AS, Hughs RD, Harrison PM. Elevated brain concentrations of 1,4-benzodiacepines in fulminant hepatic failure. N Engl J Med 1991; 325:437-48.
23. Berman DH, Leventhal RI, Gavaler JS, Gadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-1134.
24. Bihari DJ, Gimsom AES, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Sem Liver Dis 1986; 6:119-28.
25. Bismuth H, Samuel D, Gugenheim J. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107:337-341.
26. Boyer JL, Klastkin G. Pattern of necrosis in acute viral hepatitis: prognostic value of bridging (subacute hepatic necrosis). N Engl J Med 1970; 12:1063-1071.
27. Brechot C, Bernuau J, Thiers V. et al: Multiplication of hepatitis B virus in fulminant hepatitis B. Br Med J 1984; 288:270-271.
28. Brems JJ, Hiatt JR, Ramming KP, Quinones-Baldrich WJ, Busuttil RW:. Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg 1987; 154:137-141.
29. Brunt EM, White H, Marsh JW, Holtmann B, Peters MG. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology 1991; 13:1017-1021.
30. Canalese J, Gimson AES, Davis C. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23:625-629.
31. Carman RW, Fagan EA, Hadziyannis S. et al: Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991; 14:219-222.
32. Connor RW, Lorts G, Gilbert DN. Lethal herpes simplex virus type I hepatitis in a normal adult. Gastroenterology 1979; 76:590-594.
33. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med. 1990;18:286-289. 
34. Davies MH, Wilkinson SP, Hanid MA et al.: Acute liver disease with encephalopathy and renal failure in late pregnancy and the early puerperium: a study of fourteen patients. Br J Obstet Gynecol. 1980; 87:1005-1014.
35. Davis M. Protective agents for paracetamol overdose. Semin Liver Dis 1986;6:138-147.
36. Dawson DJ, Babbs C, Warnes TW, Nearly RH. Hypophosphatemia in acute liver failure. Br J Med 1987;295:1312-13
37. Dirix LY, Polson RJ, Richardson A, Williams R. Primary sepsis presenting as fulminant hepatic faliure. Q J Med 1989;73:439-62.
38. Ede RJ, Gimsom AES, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986;2:43-51.
39. Ede RJ, Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis 1986; 6:107-118.
40. Forbes A, Alexander GJM, O´GradyJG et al.: Thiopental infusion in the treatment on intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10:306-310.
41. Forbes A, Wicks C. Fulminant hepatic failure, nutrition and fat clearance. Recent Adv Nutriol 1990; 1:67A-69A.
42. Gallinger S, Greig PD, Levy G et al.: Liver transplantation for acute and subacute fulminant hepatic failure. Transplant Proc 1989; 21:2435-38.
43. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to cuantitative histological assessment of parenchymal damage. Q J Med 1975;44: 615-626.
44. Gazzard BG, Henderson JM, Williams R. Early changes following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut 1975;16:617-620. 
45. Gazzard BG, Rake MO, Flute PT, Williams R. bleeding in relation to the coagulation defect of fulminant hepatic faliure. In Williams R, Murray-LyonIM eds. Artificial liver support. London, Pitman Medical Publishing, 1975, pp: 63-67.
46. Gimson AES, Braude S, Mellon PJ. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; 2:681-683.
47. Gimson AES. O´Grady J, Ede RJ, . Late-onset hepatic failure: clinical, serological and histological features. Hepatology 1986;6:288-294.
48. Gimson AES, Tedder RS, White YS, Eddelston AL, Williams R. Serological markers in fulminant hepatitis B. Gut 1983;24:615-617.
49. Goertz J, Williams R. Histological appearance in fulminant hepatic failure with reference to aetiology, time of survival and role of immunogical processes. Digestion 1973;8:68-79.
50. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984;86:1417-1420.
51. Harrison PM, Hughes RD, Forbes A et al.: Failure of insulin and glucagon to stimulate liver regeneration in fulminant hepatic failure. J Hepatol 1990;10:332-336.
52. Harrison PM , Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxigen transport in fulminant hepatic faliure. N Engl J Med 1991;324: 1853-1857.
53. Hassanein T, Perper JA, TeppermanL, Starzl TE, Van Thiel DH. Liver failure occurring as a component of exertional heatstroke.Gastroenterology 1991; 100:1442-1447.
54. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73:639-645.
55. Keays R, Harrison PM, Wendon JA. et al.:Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br J Med. 1991; 303:1026-1029.
56. Keays R, Potter D, O'Grady J, Peachey T, Alexander G, Williams R. Intracranial and cerebral perfusion changes before, during and inmediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med 1991; 79:425-433.
57. Kosaka Y, Takase K, Kojima M.et al.  Fulminant hepatitis B: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087-1094.
58. Kramer DJ, Aggarwal S, Martin M, Darby J, Obrist W, Rosenbloom A, Murray G, Linden P, Miro A.  Management options in fulminant hepatic failure. Transplant Proc 1991; 23: 1895-1898.
59. Mori W, Shiga J, Irie H. Schwartzman reaction as a pathogenetic mechanism in fulminant hepatitis. Semin Liver Dis 1986; 6: 267-276.
60. Mullen KD, Martin JV, Mendelson WB., Bassett ML, Jones EA Could an endogenous benzodiazepine ligand contribute to hepatic encephalopaty? Lancet 1988;1:457-459.
61. Muñoz SJ, Robinson M, Northrup B. et al.  Elevated intracranial pressure and tomography of the brain in fulminant hepatic failure. Hepatology 1991; 13:209-212.
62. Neuberger J, Gimson A, Davis M, Williams R. Specific serological markers in the diagnostic of fulminant hepatic failure following halothane anaesthesia. Br J Anaesth 1983;55:15-19.
63. O´Brien CJ, Wise RJS, O´Grady JG, Williams R. Neurological sequelae in patients recovered from fulminant hepatic failure. Gut 1987; 28:93-95.
64. O´Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-445.
65. O´Grady JG, Alexander GJM, Thick M, Potter D, Calne RY, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med 1988; 69: 817-824.
66. O´Grady JG, Gimson AES, O´ Brien CJ. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-1192.
67. Peleman RR, Gavaler JS, Van Thiel D. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987;7:484-489.
68. Powell-Jackson PR, Ede RJ, Williams R. Budd-Chiari syndrome presenting as fulminant hepatic failure. Gut 1986; 27:1101-1105.
69. Rakela J, Perkins JD, Gross JB. Acute hepatic faliure: Emerging role of orthotopic liver transplantation. Mayo Clin Proc 1989; 64:424-428.
70. Rubin MH, Weston MJ, Bullock G. Abnormal platelet function and ultrastructure in fulminant hepatic failure. Q J Med 1977; 183: 339-352.
71. Sanchez-Tapias JM, Mas A, Costa J. et al: Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis. J Hepatol 1987;5:205-210.
72. Schenker S, Breen KJ, Heimberg M. Pathogenesis of tetraclycline-induced fatty liver. In: Gerok W ed. Drug and the liver. Stuttgart, FK Schattauer Verlag 1975, pp:269-280.
73. Scheuer PJ. viral hepatitis. In: McSween RNM, Anthony PP, Schuer PJ eds.. Pathology of the liver, ed 2. Edimburgh, Churchill Livingstone, 1987, pp: 202-223.
74. Sette H, Hughes RD, Langley PG, Gimson AES, Williams R. Heparin response and clearance in acute and chronic liver disease. Tromb Hemost 1985; 54:591-594.
75. Sinclair SB, Greig PD, Blendis LM. biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest 1989; 84: 1063-1069.
76. Takahashi Y,. Acute hepatic faliure: in special relation to treatment. Jpn J Med 1983;22:140-145.
77. Terblanche J, Starzl TE. Hepatic regeneration: Implications in fulminant hepatic failure. Int J Artif Organs 1979; 2:49-52.
78. Trewby PN, Warren S, Contini S. Incidence and pathophysiology of pulmonary oedema in fulminant hepatic failure. Gastroenterology 1978; 74: 859-865.
79. Wendon J, Potter D. Oxigen uptake and delivery in fulminant hepatic failure. Care Crit Ill 1989;5:55-59.
80. Wendon JA, Harison PM, Keays R, Gimson AE, Alexander GJM, Williams R. The effects of vasopressor agents and epoprostenol on systemic haemodynamics and oxigen transport in patients with fulminant hepatic failure. Hepatology 1992; 15:1067-1071.
81. Wilkinson SP, Weston MJ, ParsonsV, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8:287-292.
82. Woolf I, Sheikh N, Cullens H.et al. : Enhanced HbsAc production in pathogenesis of fulminant viral hepatitis type B. Br Med J 1976; 2:669-671.
83. Wrigth T, Hsu H, Donegan E. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115: 111-113.
84. Wyke RJ, Canalese JC, Gimson AES, Williams R. Bacteraemia in patients with fulminant hepatic failure. Liver 1982; 2:45-52.
85. Zimmerman HJ. Even enflurane. (Editorial) Hepatology 1991; 13: 1251-1253.
86. Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: analysis of 23 fatal cases. Hepatology 1982; 2:591-597.
87. Ede RJ, Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis 1986; 6: 107-118.
88. Bihari D, Holaday JW. Brain faliure. Update Intensif Care and Emergency Med. 1989; 9:1-279.
89. Fraser CL, Arieff AL. Hepatic encephalopathy. N Engl J Med 1985; 313:865-873.
90. O´Grady JG, Langley PG, Isola LM, Aledort LM, Williams R. Coagulopathy and fulminant hepatic failure. Semin Liver Dis 1986; 6: 159-163.
91. Valla D, Flejou JF, Lebrec D, Bernuau J, Rueff B, Salzmann JL, Benhamou JP. Portal hypertension and ascites in acute hepatitis: clinical, haemodynamic and histological correlations. Hepatology 1989; 10:482-487.
92. Ring-Larsen H,. Associated renal failure. In Williams R, ed. Liver Filure. Edinburgh: Churchill-Livingstone 1986;pp:72-92.
93. Bernuau J. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6:648-51.
94. Pessayre D, Larrey D. Acute and chronic drug-induced hepatitis. Bailliere´s Clin Gastroenterol 1988;2:385-422.
95. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liv Dis 1986;6:129-137.